News
J&J's oral IL-23 drug backed for psoriasis in EU
J&J's oral psoriasis drug Icotyde heads up the list of new therapies recommended for EU approval at the CHMP's July meeting.
News
Outlook finally claims FDA approval for AMD drug
After three knockbacks by the FDA, Outlook has finally pushed its therapy for age-related macular degeneration over the finish line in the US.
News
Re-rostered FDA committee backs peptide compounding
Against the advice of FDA staff scientists, an advisory committee has narrowly voted in support of looser restrictions on compounded peptides.
News
EU clears AZ's SERD camizestrant, as FDA review drags on
AstraZeneca's new breast cancer therapy Etcamah claims landmark frontline approval in the EU, but its prospects in the US are less certain.
News
Nuvalent buy delivers new cancer approval for GSK
GSK has its first approval from the $10.6bn takeover of Nuvalent, ROS1+ NSCLC therapy Jideytro, which becomes the company's first lung cancer product.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
